On December 17, 2019, the U.S. Department of Health and Human Services (HHS) took steps to increase the availability of organs for Americans on waitlists for organ transplants. In response to the Executive Order on Advancing American Kidney Health, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule to change the way organ procurement organizations are held accountable for their performance, and the Health Resources and Services Administration (HRSA) issued a proposed rule to remove financial barriers to living organ donation.
- Trump Administration Proposes New Rules to Increase Accountability and Availability of the Organ Supply (HHS Press Release, 12/17/19)
- CMS Proposed Rule: Organ Procurement Organizations (OPOs) Conditions for Coverage: Revisions to Outcome Measure Requirements for OPOs (CMS-3380-P)
- CMS Fact Sheet: OPO Conditions for Coverage Proposed Rule: Revisions to Outcome Measures for OPOs
- Health Resources & Services Administration (HRSA) Proposed Rule: Removing Financial Disincentives to Living Organ Donation (42 CFR Part 121)
Comments on the proposed rules are due by February 18, 2020 (for the HRSA rule) and February 21, 2020 (for the CMS rule).